Get Premium to unlock powerful stock data

Rtw Investments, Lp Buys Ultragenyx Pharmaceutical Inc, Apellis Pharmaceuticals Inc, Penumbra Inc, Sells , InMode, IDEAYA Biosciences Inc

Author's Avatar
Feb 15, 2022
Article's Main Image
Investment company Rtw Investments, Lp (Current Portfolio) buys Ultragenyx Pharmaceutical Inc, Apellis Pharmaceuticals Inc, Penumbra Inc, argenx SE, Sarepta Therapeutics Inc, sells , InMode, IDEAYA Biosciences Inc, Agenus Inc, Arbutus Biopharma Corp during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Rtw Investments, Lp. As of 2021Q4, Rtw Investments, Lp owns 124 stocks with a total value of $6.8 billion. These are the details of the buys and sells.

For the details of RTW INVESTMENTS, LP's stock buys and sells, go to https://www.gurufocus.com/guru/rtw+investments%2C+lp/current-portfolio/portfolio

These are the top 5 holdings of RTW INVESTMENTS, LP
  1. S&P 500 ETF TRUST ETF (SPY) - 889,739 shares, 6.17% of the total portfolio. Shares added by 1.89%
  2. Rocket Pharmaceuticals Inc (RCKT) - 15,802,802 shares, 5.04% of the total portfolio.
  3. Alnylam Pharmaceuticals Inc (ALNY) - 1,975,879 shares, 4.89% of the total portfolio. Shares added by 17.38%
  4. Thermo Fisher Scientific Inc (TMO) - 435,500 shares, 4.24% of the total portfolio. Shares added by 4.69%
  5. Masimo Corp (MASI) - 849,971 shares, 3.63% of the total portfolio. Shares added by 2.09%
New Purchase: Ultragenyx Pharmaceutical Inc (RARE)

Rtw Investments, Lp initiated holding in Ultragenyx Pharmaceutical Inc. The purchase prices were between $73.71 and $87.86, with an estimated average price of $81.26. The stock is now traded at around $72.040000. The impact to a portfolio due to this purchase was 1.69%. The holding were 1,373,284 shares as of 2021-12-31.

New Purchase: Apellis Pharmaceuticals Inc (APLS)

Rtw Investments, Lp initiated holding in Apellis Pharmaceuticals Inc. The purchase prices were between $30.74 and $49.16, with an estimated average price of $39.7. The stock is now traded at around $46.800000. The impact to a portfolio due to this purchase was 1.37%. The holding were 1,990,404 shares as of 2021-12-31.

New Purchase: Sarepta Therapeutics Inc (SRPT)

Rtw Investments, Lp initiated holding in Sarepta Therapeutics Inc. The purchase prices were between $77.28 and $99.42, with an estimated average price of $85.35. The stock is now traded at around $81.790000. The impact to a portfolio due to this purchase was 0.77%. The holding were 582,265 shares as of 2021-12-31.

New Purchase: Adicet Bio Inc (ACET)

Rtw Investments, Lp initiated holding in Adicet Bio Inc. The purchase prices were between $7.37 and $17.49, with an estimated average price of $10.83. The stock is now traded at around $14.955000. The impact to a portfolio due to this purchase was 0.77%. The holding were 3,023,744 shares as of 2021-12-31.

New Purchase: Bicycle Therapeutics PLC (BCYC)

Rtw Investments, Lp initiated holding in Bicycle Therapeutics PLC. The purchase prices were between $41.7 and $61.14, with an estimated average price of $55.41. The stock is now traded at around $48.280000. The impact to a portfolio due to this purchase was 0.77%. The holding were 869,271 shares as of 2021-12-31.

New Purchase: Science 37 Holdings Inc (SNCE)

Rtw Investments, Lp initiated holding in Science 37 Holdings Inc. The purchase prices were between $0 and $14.1, with an estimated average price of $10.89. The stock is now traded at around $8.440000. The impact to a portfolio due to this purchase was 0.72%. The holding were 3,975,000 shares as of 2021-12-31.

Added: Penumbra Inc (PEN)

Rtw Investments, Lp added to a holding in Penumbra Inc by 61.18%. The purchase prices were between $238.08 and $288, with an estimated average price of $264.5. The stock is now traded at around $231.300000. The impact to a portfolio due to this purchase was 0.99%. The holding were 620,871 shares as of 2021-12-31.

Added: argenx SE (ARGX)

Rtw Investments, Lp added to a holding in argenx SE by 126.25%. The purchase prices were between $272.01 and $353.03, with an estimated average price of $304.48. The stock is now traded at around $290.640000. The impact to a portfolio due to this purchase was 0.9%. The holding were 317,447 shares as of 2021-12-31.

Added: PMV Pharmaceuticals Inc (PMVP)

Rtw Investments, Lp added to a holding in PMV Pharmaceuticals Inc by 268.08%. The purchase prices were between $19.99 and $30.01, with an estimated average price of $24.06. The stock is now traded at around $17.180000. The impact to a portfolio due to this purchase was 0.74%. The holding were 2,980,960 shares as of 2021-12-31.

Added: Protagonist Therapeutics Inc (PTGX)

Rtw Investments, Lp added to a holding in Protagonist Therapeutics Inc by 48.25%. The purchase prices were between $17.63 and $37.1, with an estimated average price of $31.91. The stock is now traded at around $28.550000. The impact to a portfolio due to this purchase was 0.42%. The holding were 2,599,822 shares as of 2021-12-31.

Added: Cytokinetics Inc (CYTK)

Rtw Investments, Lp added to a holding in Cytokinetics Inc by 28.06%. The purchase prices were between $34.35 and $46.38, with an estimated average price of $38.74. The stock is now traded at around $37.630000. The impact to a portfolio due to this purchase was 0.37%. The holding were 2,561,182 shares as of 2021-12-31.

Added: CytomX Therapeutics Inc (CTMX)

Rtw Investments, Lp added to a holding in CytomX Therapeutics Inc by 330.40%. The purchase prices were between $3.87 and $7.39, with an estimated average price of $5.86. The stock is now traded at around $4.050000. The impact to a portfolio due to this purchase was 0.29%. The holding were 6,029,700 shares as of 2021-12-31.

Sold Out: (DRNA)

Rtw Investments, Lp sold out a holding in . The sale prices were between $19.26 and $38.25, with an estimated average price of $29.18.

Sold Out: InMode Ltd (INMD)

Rtw Investments, Lp sold out a holding in InMode Ltd. The sale prices were between $63.78 and $97.86, with an estimated average price of $80.18.

Sold Out: LifeSci Acquisition II Corp (LSAQ)

Rtw Investments, Lp sold out a holding in LifeSci Acquisition II Corp. The sale prices were between $9.01 and $9.72, with an estimated average price of $9.33.

Sold Out: Helix Acquisition Corp (HLXA)

Rtw Investments, Lp sold out a holding in Helix Acquisition Corp. The sale prices were between $9.86 and $10.15, with an estimated average price of $9.93.

Sold Out: Berkeley Lights Inc (BLI)

Rtw Investments, Lp sold out a holding in Berkeley Lights Inc. The sale prices were between $17.39 and $25.74, with an estimated average price of $21.56.

Sold Out: Scholar Rock Holding Corp (SRRK)

Rtw Investments, Lp sold out a holding in Scholar Rock Holding Corp. The sale prices were between $24.14 and $35.18, with an estimated average price of $27.49.



Here is the complete portfolio of RTW INVESTMENTS, LP. Also check out:

1. RTW INVESTMENTS, LP's Undervalued Stocks
2. RTW INVESTMENTS, LP's Top Growth Companies, and
3. RTW INVESTMENTS, LP's High Yield stocks
4. Stocks that RTW INVESTMENTS, LP keeps buying
Rating:
0 / 5 (0 votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus